ArticleFrontiers in endocrinology2026
Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission.
Enes Ucgul et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.